ASCOT: a tale of two treatment regimens

doi:10.1136/bmj.331.7523.1022

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Don't lose your head over ASCOT

David G Phizackerley, prescribing team manager (david.phizackerley@wsx-pct.nhs.uk)

Western Sussex Primary Care Trust, Chichester PO19 6FX

EDITOR—McDougall et al reviewed the evidence from ASCOT (the Anglo Scandinavian cardiac outcomes trial).1 For patients with hypertension and for the clinicians helping to manage their blood pressure this must be the best of times and the worst of times. The best of times—currently we have a wealth of clinical trials on the management of blood pressure, giving us a mass of data, statistics and information to absorb. The worst of times—whenever a new trial is published, the …